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Aims: While great strides have been made in the elucidation of the physiological and 
pharmacological roles of heme oxygenases (HO) in experimental animals and humans, 
there is still an enormous potential for further research discoveries and their application 
in therapeutics. We have identified the need for improved pharmacological tools for 
Heme Oxygenase research, and have conducted a program to design and test new 
compounds for their potential as selective inhibitors and activators of HO-1 and HO-2. 
 
Methods & Results: Our first undertaking exploited the "hit" compound, (2S,4S)-  
2-[2-(4-chlorphenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4-[((4-
aminophenyl)thio)methyl]-1,3-dioxolane, QC-1.  New candidates were designed on the 
basis of QC-1, and synthesized in our laboratories; they were then tested for HO 
inhibition using spleen and brain microsomal preparations as sources of HO-1 and HO-2, 
respectively.  Many QC-xx compounds were identified as inhibitors of both HO-1 and 
HO-2, while a subset were found to be selective for HO-1.  X-ray crystallography has 
revealed that these inhibitors bind to the substrate, heme, in the active site.  Subsequently, 
we screened compound libraries and identified "hits" as candidates for new skeletons in 
the design of selective inhibitors and activators of HO-2.  The latter compounds appear to 
be selective for HO-2 in that we have observed up to 30-fold activation of HO-2 and no 
activation of HO-1. 
 
Conclusions: The novel compounds that have resulted from this work are being 
evaluated for their use as tools for the ongoing investigation of heme oxygenases, and 
their roles in health and disease.  
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